ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Genomics England Limited

Genomics England Limited is an active company incorporated on 17 April 2013 with the registered office located in London, Greater London. Genomics England Limited was registered 12 years ago.
Status
Active
Active since incorporation
Company No
08493132
Private limited company
Age
12 years
Incorporated 17 April 2013
Size
Large
Balance sheet is over £27M
Over 250 employees
Confirmation
Submitted
Dated 17 April 2025 (4 months ago)
Next confirmation dated 17 April 2026
Due by 1 May 2026 (7 months remaining)
Last change occurred 4 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2025 (12 months)
Accounts type is Full
Next accounts for period 31 March 2026
Due by 31 December 2026 (1 year 3 months remaining)
Contact
Address
Level 21 One Canada Square
Canada Square
London
E14 5AB
England
Address changed on 19 Apr 2023 (2 years 4 months ago)
Previous address was Dawson Hall Charterhouse Square London EC1M 6BQ England
Telephone
02078825030
Email
Unreported
People
Officers
15
Shareholders
1
Controllers (PSC)
1
Director • Director • Chair • British • Lives in England • Born in Feb 1959
Director • Consultant • British • Lives in England • Born in Oct 1979
Director • Chief Scientist • British,australian • Lives in England • Born in Jan 1964
Director • Doctor • British • Lives in England • Born in Jun 1976
Director • Museum Director • British,new Zealander • Lives in England • Born in Jul 1964
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Condorcet Partners Limited
Jonathan Richard Symonds is a mutual person.
Active
Rye Golf Club Company Limited
Richard Henry Meddings is a mutual person.
Active
British Heart Foundation
Dr Annalisa Mary Jenkins is a mutual person.
Active
National Centre For Universities And Business
Jonathan Richard Symonds is a mutual person.
Active
GSK Plc
Jonathan Richard Symonds is a mutual person.
Active
Phaim Pharma Ltd
Dr Annalisa Mary Jenkins is a mutual person.
Active
Oribiotech Ltd
Dr Annalisa Mary Jenkins is a mutual person.
Active
Cyte Limited
Dr Annalisa Mary Jenkins is a mutual person.
Active
Brands
Genomics England
Genomics England focuses on genomic testing and research initiatives in partnership with the NHS to improve patient care and outcomes..
Financials
Net Assets, Total Assets & Total Liabilities (2016–2025)
Period Ended
31 Mar 2025
For period 31 Mar31 Mar 2025
Traded for 12 months
Cash in Bank
£57.93M
Increased by £37.94M (+190%)
Turnover
£29.94M
Increased by £729K (+2%)
Employees
540
Increased by 23 (+4%)
Total Assets
£88.44M
Increased by £39.3M (+80%)
Total Liabilities
-£25.47M
Increased by £3.26M (+15%)
Net Assets
£62.97M
Increased by £36.04M (+134%)
Debt Ratio (%)
29%
Decreased by 16.4% (-36%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 24 Jul 2025
John Irving Bell Resigned
4 Months Ago on 30 Apr 2025
Confirmation Submitted
4 Months Ago on 23 Apr 2025
Richard Henry Meddings Resigned
5 Months Ago on 31 Mar 2025
Douglas John Gurr Resigned
7 Months Ago on 3 Feb 2025
Full Accounts Submitted
1 Year 1 Month Ago on 6 Aug 2024
Confirmation Submitted
1 Year 4 Months Ago on 17 Apr 2024
Dr Douglas John Gurr Appointed
1 Year 5 Months Ago on 20 Mar 2024
Andrew Eland Resigned
1 Year 7 Months Ago on 25 Jan 2024
Mr Richard Henry Meddings Appointed
1 Year 9 Months Ago on 4 Dec 2023
Get Credit Report
Discover Genomics England Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 7 July 2025
Submitted on 5 Aug 2025
Full accounts made up to 31 March 2025
Submitted on 24 Jul 2025
Termination of appointment of John Irving Bell as a director on 30 April 2025
Submitted on 8 May 2025
Confirmation statement made on 17 April 2025 with updates
Submitted on 23 Apr 2025
Termination of appointment of Richard Henry Meddings as a director on 31 March 2025
Submitted on 1 Apr 2025
Statement of capital following an allotment of shares on 3 February 2025
Submitted on 1 Apr 2025
Termination of appointment of Douglas John Gurr as a director on 3 February 2025
Submitted on 5 Feb 2025
Statement of capital following an allotment of shares on 23 September 2024
Submitted on 9 Oct 2024
Full accounts made up to 31 March 2024
Submitted on 6 Aug 2024
Statement of capital following an allotment of shares on 30 April 2024
Submitted on 7 May 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year